Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Pharmaceuticals Market Briefing 2017 - New Methods for Drug Discovery is Expected to Drive the $1300 Billion Market - ResearchAndMarkets.com

Research and Markets
Posted on: 30 Jan 18

The "Pharmaceuticals Market Global Briefing 2017" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical market is expected to reach over $1300 billion in 2020.

One of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems.

Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.

The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.

One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.

Scope

  • Markets Covered: Pharmaceuticals/Drugs/Medicinal Drugs and Biologics.
  • Time Series: Five years historic and forecast.
  • Data: Market value in $ billions.

Companies Mentioned

  • Pfizer
  • Roche
  • GlaxoSmithKline
  • Merck & Co.
  • Sanofi
  • Gilead Sciences
  • Johnson & Johnson
  • Novartis
  • AbbVie
  • Amgen

For more information about this report visit https://www.researchandmarkets.com/research/rqs2ps/global?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180130006387/en/

Business Wire
www.businesswire.com

Last updated on: 30/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.